Up to 185,000 Australian women have increased risk of cancer, infertility, stillbirth and early menopauseSydney, 6 October 2011: A new study released today in the New England Journal of Medicine* has revealed women exposed to anti-miscarriage drug DES in utero are at an increased risk of at least 12 adverse health conditions - in some cases up to three-times that of other women.
An estimated 185,000 women across Australia have been exposed in utero to this drug.
The study of medical records found women exposed to DES in utero are at double the risk of suffering infertility, at three times the risk of preterm delivery and almost twice as likely to develop breast cancer at 40 years of age or older.
DES Action Australia-NSW says this study proves what has been implied by anecdotal evidence. Australian women who have suffered one or a combination of these health conditions should speak to their doctors if they suspect their mother took DES or Stilboestrol while pregnant.
"DES exposed women require special medical care, including DES examinations and mammograms annually. This study must act as a wake up call for health authorities to promote information about DES directly to Australians in public health programs. Too often we hear from people, who for decades have been oblivious to the harmful effects of DES, the fact of their exposure and the care they need," says Carol Devine, coordinator of the DES Action group.
The study combined data from three studies in the 1970s with continued long-term follow-up of more than 4,600 women exposed in utero to DES, compared to unexposed women.
The study reports that the drug, developed in 1938, was found to be of no health benefit in four clinical trials conducted in the 1950s. Despite this, it was marketed and prescribed in many countries around the word, including Australia, until up to 1971 and sometimes beyond.
"Many women may not know they were exposed to DES, as their mothers may not recall taking the drug and medical records can go amiss over time. But if women do have a history of these health conditions, they should ask their doctors for an assessment of DES exposure probability and possible referral to a DES knowledgeable specialist," says Devine.
Women should contact DES Action Australia-NSW for more information about DES by phoning 02 98754820 or visiting www.desnsw.blogspot.com
LIFETIME RISKS OF A DES DAUGHTER- 2.28 times the risk of cervical intraepithelial neoplasia, grade 2 or above
- 2.45 times the risk of stillbirth
- 2.35 times the risk of early menopause
- 1.64 times the risk of spontaneous abortion
- 3.72 times the risk of ectopic pregnancy
-END-
*New England Journal of Medicine 365: 14 October 6 2011 nejm.org
For more information, contact:
Carol Devine, DES Action Australia-NSW
E: c_devine@bigpond.net.au
P: (02) 98754820
On You Tube US researcher, Dr Arthur Herbst provides a most interesting account of the finding of the DES link to cancer. This footage commemorates Arthur L. Herbst and the 40th anniversary of his landmark DES paper. Your doctor might also be interested in this. Here is the link:
In the October 6 New England Journal of Medicine (NEJM) US Epidemiologist, Dr Robert Hoover and his colleagues estimated the absolute risks of 12 health outcomes associated with prenatal exposure to DES, including certain cancers and reproductive problems such as infertility, ectopic pregnancies and preterm births.
WONDER DRUG screenwriter Caitlin McCarthy has been nominated for the 2011 Presidential Citizens Medal (www.whitehouse.gov/citizensmedal). Due to Caitlin's efforts and work with the offices of Senators Kerry and Brown, the FDA finally acknowledged DES as a "tragedy" in 2011 after 40 years. Caitlin also champions DES awareness through her screenwriting, blogging, activism, public speaking, and government/media relations.
Up to 185,000 Australian women have increased risk of cancer, infertility, stillbirth and early menopause
Caitlin McCarthy has written about her DES experience for the US Readers'Digest Life Story competition. Her winning will mean showcasing the DES cause world-wide. You can help by voting for Caitlin's story EVERY DAY until November 15th at
